Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: AIDS Care. 2016 Jun 13;28(11):1355–1364. doi: 10.1080/09540121.2016.1189496

Figure 1. Trends in Antiretroviral Use and Viral Suppression among DC Cohort participants, January 2011–June 2014.

Figure 1

This figure presents the proportion of participants who were on antiretroviral (ARV) treatment, had at least one VL test result, and were suppressed (VL<200 copies/ml) at each 6-month interval between January 2011 and June 2014. Among those who were not suppressed, the median VL and percentage of participants who had a VL over 100,000 copies/ml are also shown.